MYOS Canine Muscle Formula - Blog

MYOS CORP Announces Peer Reviewed Study on The Impact of Fortetropin in Arthritic Dogs Has Been Accepted for Publication   Dogs Supplemented with Fortetropin® Experienced Clinically Significant Improvements in Osteoarthritis   CEDAR KNOLLS, N.J., March 29, 2022--  MYOS CORP, a research-based, advanced nutrition company, announces that a new peer...

Results of Study at University of Florida Form Basis for Company's Entry into Feline Market with Launch of MYOS Feline Muscle Health Formula.   CEDAR KNOLLS, N.J., June 15, 2021 /PRNewswire/ -- MYOS Corp ("MYOS" or the "Company"), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, anno...

Company will share exciting updates with animal health industry leaders at Booth #2442   CEDAR KNOLLS, N.J., June 1, 2021 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, announced today that it will be attending in-person the 2021...

Partnership will allow for scaling of Company's thriving Direct-to-Vet business throughout North America   CEDAR KNOLLS, N.J., March 18, 2021 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, announced today that it has entered a pa...

Seven prestigious thought leaders from private practice and academia will guide MYOS CORP through its next stage of growth in animal health industry. CEDAR KNOLLS, N.J., Feb. 2, 2021 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health,...

Dogs Supplemented with Fortetropin® Experienced Statistically Significant Improvements in LOAD (Liverpool Osteoarthritis in Dogs) Scores CEDAR KNOLLS, N.J., Dec. 9, 2020 /PRNewswire/ -- MYOS Corp,a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, announced positive results today from a...

Science-Backed Product is Recommended by Key Opinion Leaders in Veterinary Medicine. CEDAR KNOLLS, N.J., April 28, 2020 /PR Newswire/-- MYOS RENS Technology Inc. (“MYOS” or “the Company”) (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps build lean muscle, announced today that it...

100-Dog Study Showed that Dogs Receiving Fortetropin® Experienced Reduced Muscle Loss and Improved Recovery